摘要
Androgen receptor-targeted therapy improves survival in castration-resistant prostate cancer (CRPC). However, almost all patients with CRPC eventually develop secondary resistance to these drugs. Therefore, alternative therapeutic approaches for incurable metastatic CRPC are urgently needed. Unfolded protein response (UPR) is regarded as a cytoprotective mechanism that removes misfolded proteins in rapidly proliferating tumor cells. However, acute activation of the UPR directly leads to tumor cell death. This study has shown that WJ-644A, a novel small molecule activator of UPR, potently inhibited the proliferation of prostate cancer cells and caused tumor regression with a good safety profile in multiple animal models. Mechanistically, we have identified that WJ-644A induced cell methuosis and autophagy upon UPR activation. Our study not only identifies the UPR as an actionable target for CRPC treatment, but also establishes WJ-644A as a novel UPR activator that has potential therapeutic value for CRPC.
学科与关键词
- Regression of Castration-Resistant Prostate Cancer by a Novel Compound HG122Cong, Xiaonan; He, Yundong; Wu, Haigang; Wang, Dingxiang; Liu, Yongrui; Shao, Ting; Liu, Mingyao; Yi, Zhengfang; Zheng, Jianghua; Peng, Shihong*; Ding, Tao*Frontiers in Oncology, 2021, 11: 650919.被引 4
- Catalase Inhibitors with Dual Pro-Oxidant Effect as New Therapeutic Agents in Castration-Resistant Prostate CancerChen, Yuan-Yuan; Liang, Hao-Qi; Liu, Meng-Ting; Huang, Wei; Yi, Peng-Fei; Yuan, Si-Qi; Mei, Long-Can; Hu, Ying-Hui; Cao, Ya-Ya; Hao, Ge-Fei; Zhang, Dan*; Yang, Guang-Fu*ADVANCED THERAPEUTICS, 2021, 4(3): 2000164.被引 1
- Regulation and targeting of androgen receptor nuclear localization in castration-resistant prostate cancerLv, Shidong; Song, Qiong; Chen, Guang; Cheng, Erdong; Chen, Wei; Cole, Ryan; Wu, Zeyu; Pascal, Laura E.; Wang, Ke; Wipf, Peter; Nelson, Joel B.; Wei, Qiang; Huang, Wenhua*; Wang, Zhou*Journal of Clinical Investigation, 2021, 131(4): e141335.被引 34
